| Cardiovascular Risk Management |
1 |
1 |
| Social Determinants of Health |
0 |
0.99 |
| Transgender |
0 |
0.98 |
| Biomarker |
0 |
0.97 |
| Heart Failure (HF) |
0 |
0.36 |
| Hormonal Therapy |
0 |
0.27 |
| Deep Venous Thrombosis |
0 |
0.25 |
| Pulmonary Embolism |
0 |
0.25 |
| Heart |
0 |
0.22 |
| Troponin |
0 |
0.22 |
| Cardiovascular Imaging |
0 |
0.19 |
| Myocardial Infarction (MI) |
0 |
0.19 |
| Acute Myocardial Infarction (MI) |
0 |
0.09 |
| Birth |
0 |
0.09 |
| Iowa |
0 |
0.09 |
| Psychosocial |
0 |
0.09 |
| Testosterone |
0 |
0.09 |
| Washington |
0 |
0.09 |
| Chest Pain |
0 |
0.08 |
| Angina Pectoris |
0 |
0.07 |
| B-Type Natriuretic Peptide |
0 |
0.06 |
| Pain Management |
0 |
0.05 |
| Brain |
0 |
0.04 |
| Cardiovascular disease |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Infarction |
0 |
0.04 |
| LGBT |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Politics |
0 |
0.04 |
| Primary Care |
0 |
0.04 |
| Puberty |
0 |
0.04 |
| Thorax |
0 |
0.04 |
| Triage |
0 |
0.04 |